Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Stevenson

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Menopause (New York, N.Y.)|May 10, 2005
Bone mineral density in postmenopausal women treated with a vaginal ring delivering systemic doses of estradiol acetateFarook Al-Azzawi, Belinda Lees, John Thompson, et al.
Endocrine Connections|March 8, 2022
Menopause-associated risk of cardiovascular diseasePanagiotis Anagnostis, Irene Lambrinoudaki, John C Stevenson, et al.
Women'S Health (London, England)|August 6, 2019
Hormone therapy for first-line management of menopausal symptoms: Practical recommendationsSantiago Palacios, John C Stevenson, Katrin Schaudig, et al.
Clinical Endocrinology|January 12, 2020
Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trialPayal Trupti Kotecha, Ian F Godsland, David Crook, et al.
Current Pharmaceutical Design|October 16, 2018
Should we Consider Lipoprotein (a) in Cardiovascular Disease Risk Assessment in Patients with Familial Hypercholesterolaemia?Panagiotis Anagnostis, Pavlos Siolos, Dimitrios Krikidis, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2015
A Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Lipid Parameters in Postmenopausal Women From the Selective Estrogens, Menopause, and Response to Therapy (SMART) TrialsJohn C Stevenson, Arkadi Chines, Kaijie Pan, et al.
BMJ (Clinical Research Ed.)|February 18, 2010
Drug firm conflicting interests. If only WHI was done wellJohn C Stevenson, Howard N Hodis, James H Pickar, et al.
International Journal of Clinical Practice|December 30, 2016
Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic optionsPanagiotis Anagnostis, Spyridon Karras, Irene Lambrinoudaki, et al.
Endocrine Reviews|March 22, 2017
Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical ImplicationsFranck Mauvais-Jarvis, JoAnn E Manson, John C Stevenson, et al.
Atherosclerosis|June 30, 2009
Coronary heart disease and menopause management: the swinging pendulum of HRTJohn C Stevenson, Howard N Hodis, James H Pickar, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Menopause (New York, N.Y.)|May 10, 2005
Bone mineral density in postmenopausal women treated with a vaginal ring delivering systemic doses of estradiol acetateFarook Al-Azzawi, Belinda Lees, John Thompson, et al.
Endocrine Connections|March 8, 2022
Menopause-associated risk of cardiovascular diseasePanagiotis Anagnostis, Irene Lambrinoudaki, John C Stevenson, et al.
Women'S Health (London, England)|August 6, 2019
Hormone therapy for first-line management of menopausal symptoms: Practical recommendationsSantiago Palacios, John C Stevenson, Katrin Schaudig, et al.
Clinical Endocrinology|January 12, 2020
Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trialPayal Trupti Kotecha, Ian F Godsland, David Crook, et al.
Current Pharmaceutical Design|October 16, 2018
Should we Consider Lipoprotein (a) in Cardiovascular Disease Risk Assessment in Patients with Familial Hypercholesterolaemia?Panagiotis Anagnostis, Pavlos Siolos, Dimitrios Krikidis, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2015
A Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Lipid Parameters in Postmenopausal Women From the Selective Estrogens, Menopause, and Response to Therapy (SMART) TrialsJohn C Stevenson, Arkadi Chines, Kaijie Pan, et al.
BMJ (Clinical Research Ed.)|February 18, 2010
Drug firm conflicting interests. If only WHI was done wellJohn C Stevenson, Howard N Hodis, James H Pickar, et al.
International Journal of Clinical Practice|December 30, 2016
Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic optionsPanagiotis Anagnostis, Spyridon Karras, Irene Lambrinoudaki, et al.
Endocrine Reviews|March 22, 2017
Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical ImplicationsFranck Mauvais-Jarvis, JoAnn E Manson, John C Stevenson, et al.
Atherosclerosis|June 30, 2009
Coronary heart disease and menopause management: the swinging pendulum of HRTJohn C Stevenson, Howard N Hodis, James H Pickar, et al.
Pageof 10